bullish
Venus Medtech IPO Initiation: The Heart of the Business
756 Views12 Aug 2019 15:21
Venus MedTech Hangzhou Inc (1392140D CH) is a leading transcatheter heart valve medical device company in China. VenusA-Valve, a self-developed...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 9-minute read)
Discussions
(Paid Plans Only)
x